Percentage of patients 66 years of age and older who have ever received a pneumococcal vaccine
Patients 66 years of age and older with a visit during the measurement period
Equals Initial Population
Exclude patients who are in hospice care for any part of the measurement period.
Patients who received a pneumococcal vaccination on or after their 60th birthday and before the end of the measurement period; or ever had an adverse reaction to the vaccine before the end of the measurement period
Not Applicable
None
Higher score indicates better quality
Patient self-report for procedures as well as immunizations should be recorded in 'Procedure, Performed' template or 'Immunization, Administered' template in QRDA-1.
This eCQM is a patient-based measure.
This version of the eCQM uses QDM version 5.5. Please refer to the eCQI resource center for more information on the QDM.
The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.
Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
Percentage of patients 66 years of age and older who have received a pneumococcal vaccine
Patients 65 years of age and older with a visit during the measurement period
Patients 66 years of age and older at the start of the measurement period with a visit during the measurement period
Patients who have ever received a pneumococcal vaccination before the end of the measurement period
Patients who received a pneumococcal vaccination on or after their 60th birthday and before the end of the measurement period
Patient self-report for procedures as well as immunization s should be recorded in 'Procedure, Performed' template or 'Immunization, Administered' template in QRDA-1.
ACIP (Kobayashi, 2015) provides guidance about the proper interval and relative timing for the administration of two pneumococcal vaccines; this measure assesses whether patients have received at least one of either vaccine.
This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM.
*Note: There is a known issue on CMS127v10. See issue EKI-14 on the ONC eCQM Known Issues Dashboard for details.
Updated the eCQM version number.
Measure Section: eCQM Version Number
Source of Change: Annual Update
Revised the age in the description to align with updates limiting the numerator to the PPSV23 vaccine.
Measure Section: Description
Source of Change: Measure Lead
Updated copyright.
Measure Section: Copyright
Updated the rationale to align with current evidence.
Measure Section: Rationale
Updated the clinical recommendation statement to align with current clinical recommendations.
Measure Section: Clinical Recommendation Statement
Updated references.
Measure Section: Reference
Updated the guidance to clarify the measure intent and support implementation.
Measure Section: Guidance
Revised the age in the initial population to align with updates limiting the numerator to the PPSV23 vaccine.
Measure Section: Initial Population
Replaced 'overlaps' or 'overlapping' in the denominator exclusions with plain language to clarify the measure intent.
Measure Section: Denominator Exclusions
Revised the numerator statement to align with the clinical recommendations related to age and adverse reactions.
Measure Section: Numerator
Added online assessments and telephone visits as appropriate encounters based on the increased use of telehealth services.
Revised the age in the Initial Population definition to align with updates limiting the numerator to the PPSV23 vaccine.
Revised the Numerator definition and added two definitions, Has Pneumococcal Polysaccharide Vaccine 23 Administered and Has Pneumococcal Vaccine Adverse Reaction, to align with the clinical recommendations related to age and adverse reactions.
Updated the version number of the Measure Authoring Tool (MAT) Global Common Functions Library (MATGlobalCommonFunctions-6.2.000). Updated the 'Inpatient Encounter' definition to include a 'day of' timing clarification. Added the following timing functions: Normalize Interval, Has Start, Has End, Latest, Latest Of, Earliest, and Earliest Of. Please see individual measure details for application of specific timing functions.
Measure Section: Multiple Sections
Source of Change: Standards Update
Added new NormalizeInterval function to timing attributes to decrease implementation burden due to variable use of timing attributes for select QDM data types. The NormalizeInterval function was applied, where applicable, for the following data elements: Assessment, Performed; Device, Applied; Diagnostic Study, Performed; Intervention, Performed; Laboratory Test, Performed; Medication, Administered; Medication, Dispensed; Physical Exam, Performed; Procedure, Performed; Substance, Administered.
Updated Hospice CQL Library to version 3.0.000.
The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.
Added value set Telephone Visits (2.16.840.1.113883.3.464.1003.101.12.1080) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Added value set Online Assessment (2.16.840.1.113883.3.464.1003.101.12.1089) based on change in measure requirements/measure specification.
Added direct reference codes CPT codes (90732, 99211) based on change in measure requirements/measure specification.
Added direct reference code SNOMED CT code (293116002) based on change in measure requirements/measure specification.
Replaced value set Pneumococcal Vaccine Administered (2.16.840.1.113883.3.464.1003.110.12.1034) with value set Pneumococcal Polysaccharide 23 Vaccine (2.16.840.1.113883.3.464.1003.110.12.1089) based on change in measure requirements/measure specification.